Biological response and cell death signaling pathways modulated by tetrahydroisoquinoline-based aldoximes in human cells.

[1]  S. Pirkmajer,et al.  Cytotoxicity-related Effects of Imidazolium and Chlorinated Bispyridinium Oximes in SH-SY5Y Cells , 2022, Arhiv za higijenu rada i toksikologiju.

[2]  V. Neves,et al.  Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules , 2021, ACS medicinal chemistry letters.

[3]  S. Pirkmajer,et al.  Activation of (un)regulated cell death as a new perspective for bispyridinium and imidazolium oximes , 2021, Archives of Toxicology.

[4]  J. Rueff,et al.  The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family , 2021, Journal of xenobiotics.

[5]  J. Čapek,et al.  Effects of Charged Oxime Reactivators on the HK-2 Cell Line in Renal Toxicity Screening. , 2021, Chemical research in toxicology.

[6]  S. Pirkmajer,et al.  Vitamin B3-Based Biologically Active Compounds as Inhibitors of Human Cholinesterases , 2020, International journal of molecular sciences.

[7]  S. Pirkmajer,et al.  Ouabain Suppresses IL-6/STAT3 Signaling and Promotes Cytokine Secretion in Cultured Skeletal Muscle Cells , 2020, Frontiers in Physiology.

[8]  F. Worek,et al.  Organophosphorus compounds and oximes: a critical review , 2020, Archives of Toxicology.

[9]  P. Renard,et al.  Pharmacokinetic evaluation of brain penetrating morpholine-3-hydroxy-2-pyridine oxime as an antidote for nerve agent poisoning. , 2020, ACS chemical neuroscience.

[10]  J. Correia,et al.  DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport across the Blood-Brain Barrier. , 2020, Current pharmaceutical design.

[11]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[12]  Delphine De Sutter,et al.  A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway , 2018, Scientific Data.

[13]  P. Taylor,et al.  Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure , 2018, The Journal of Pharmacology and Experimental Therapeutics.

[14]  J. Sussman,et al.  Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration. , 2018, Chemistry.

[15]  D. Green,et al.  Caspase‐8: regulating life and death , 2017, Immunological reviews.

[16]  P. Renard,et al.  An easy method for the determination of active concentrations of cholinesterase reactivators in blood samples: Application to the efficacy assessment of non quaternary reactivators compared to HI-6 and pralidoxime in VX-poisoned mice. , 2017, Chemico-biological interactions.

[17]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[18]  Jan Kihlberg,et al.  How Big Is Too Big for Cell Permeability? , 2017, Journal of medicinal chemistry.

[19]  Ping Li,et al.  Caspase-9: structure, mechanisms and clinical application , 2017, Oncotarget.

[20]  David K. Johnson,et al.  Ultra-High-Throughput Structure-Based Virtual Screening for Small-Molecule Inhibitors of Protein-Protein Interactions , 2016, J. Chem. Inf. Model..

[21]  R. Nichols,et al.  Nicotinic Acetylcholine Receptors Sensitize a MAPK-linked Toxicity Pathway on Prolonged Exposure to β-Amyloid* , 2015, The Journal of Biological Chemistry.

[22]  J. Baell,et al.  Chemistry: Chemical con artists foil drug discovery , 2014, Nature.

[23]  J. Snyder,et al.  Discovery of tetrahydroisoquinoline-based CXCR4 antagonists. , 2013, ACS medicinal chemistry letters.

[24]  F. Worek,et al.  The value of novel oximes for treatment of poisoning by organophosphorus compounds. , 2013, Pharmacology & therapeutics.

[25]  L. Boise,et al.  Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis , 2013, BMC Cell Biology.

[26]  Fabian Müller,et al.  Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects , 2013, Pharmacological Reviews.

[27]  G. H. Thoresen,et al.  Are cultured human myotubes far from home? , 2013, Cell and Tissue Research.

[28]  Shiying Yu,et al.  Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation. , 2013, International journal of oncology.

[29]  K. Kuča,et al.  The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors , 2013, Archives of Toxicology.

[30]  K. Kuča,et al.  Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. , 2010, Chemico-biological interactions.

[31]  K. Kuča,et al.  Interaction of nerve agent antidotes with cholinergic systems. , 2010, Current medicinal chemistry.

[32]  Hong-rong Xie,et al.  SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. , 2010, Chinese medical journal.

[33]  Y. Yada,et al.  The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson’s disease , 2009, Journal of neurochemistry.

[34]  David Saggerson,et al.  Malonyl-CoA, a key signaling molecule in mammalian cells. , 2008, Annual review of nutrition.

[35]  G. Petroianu,et al.  Entry of oximes into the brain: a review. , 2008, Current medicinal chemistry.

[36]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[37]  K. Kuča,et al.  In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. , 2006, Toxicology.

[38]  R. Ceddia,et al.  Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells Published, JLR Papers in Press, November, 22, 2005. , 2006, Journal of Lipid Research.

[39]  H. Pajouhesh,et al.  Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.

[40]  E. Jiménez,et al.  Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells , 2005, Journal of cellular physiology.

[41]  T. Smart,et al.  HEK293 cell line: a vehicle for the expression of recombinant proteins. , 2005, Journal of pharmacological and toxicological methods.

[42]  T. Andersson,et al.  Protein Phosphatase 2A Regulates Apoptosis in Neutrophils by Dephosphorylating Both p38 MAPK and Its Substrate Caspase 3* , 2005, Journal of Biological Chemistry.

[43]  M. Fromm,et al.  Importance of P-glycoprotein at blood-tissue barriers. , 2004, Trends in pharmacological sciences.

[44]  Y. Asakawa,et al.  An ent-kaurene diterpene enhances apoptosis induced by tumor necrosis factor in human leukemia cells. , 2004, Planta medica.

[45]  J. Blenis,et al.  ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.

[46]  N. J. Hewitt,et al.  Phase I and II enzyme characterization of two sources of HepG2 cell lines , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[47]  J. Polli,et al.  Rational use of in vitro P-glycoprotein assays in drug discovery. , 2001, The Journal of pharmacology and experimental therapeutics.

[48]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[49]  G. Feldmann,et al.  Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: Morphology and immunocytochemical studies of hepatic-secreted proteins , 1989, In Vitro Cellular & Developmental Biology.

[50]  T. Decker,et al.  A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. , 1988, Journal of immunological methods.

[51]  N. Bodor,et al.  Delivery of a quaternary pyridinium salt across the blood-brain barrier by its dihydropyridine derivative , 1975, Science.

[52]  B. Calesnick,et al.  Human toxicity of various oximes. 2-Pyridine aldoxime methyl chloride, its methane sulfonate salt, and 1,1'-trimethylenebis-(4-formylpyridinium chloride). , 1967, Archives of environmental health.

[53]  S. Yeap,et al.  Apoptotic induction and inhibition of NF-κB signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2′-oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis: an in vitro study , 2017, OncoTargets and therapy.

[54]  B. Davis,et al.  Learning from our mistakes : The ‘ unknown knowns ’ in fragment screening , 2013 .

[55]  D. Langford,et al.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. , 2013, Methods in molecular biology.

[56]  K. Kuča,et al.  Oxime reactivators and their in vivo and in vitro effects on nicotinic receptors. , 2011, Physiological research.

[57]  S. Ohta,et al.  Cytotoxicity of 17 tetrahydroisoquinoline derivatives in SH-SY5Y human neuroblastoma cells is related to mitochondrial NADH-ubiquinone oxidoreductase inhibition. , 2007, Neurotoxicology.

[58]  J Deisenhofer,et al.  Structure and function of cytochromes P450: a comparative analysis of three crystal structures. , 1995, Structure.

[59]  R. Zager,et al.  HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.